Key result
Administering low molecular weight heparin 2 hours before versus 2 hours after hip replacement surgery resulted in similar rates of deep vein thrombosis.
Why the study?
Does administering the first dose of low molecular weight heparin 2 hours before versus 2 hours after surgery affect the incidence of deep vein thrombosis in patients undergoing hip replacement surgery?
Does administering the first dose of low molecular weight heparin 2 hours before versus 2 hours after surgery affect the incidence of deep vein thrombosis in patients undergoing hip replacement surgery?
The timing of the first dose of low molecular weight heparin (2 hours before vs 2 hours after surgery) does not significantly affect its efficacy in preventing deep vein thrombosis after hip replacement surgery.
Answers are grounded in this paper and cite their sources.
May not affect DVT prevention timing in hip replacement; hypothesis-generating and should not change practice without RCTs.
The efficacy of two treatment protocols with a low molecular weight heparin used for the prevention of post-operative deep vein thrombosis was compared in 40 patients undergoing hip replacement surgery. The aim was to assess whether the different timing--2 hours before (Group A, 19 patients) or 2 hours after (Group B, 21 patients) the surgical operation--of the first dose administered (15,000 aXaU) of a therapeutic cycle of 7 days could affect the results, both with respect to the preventive efficacy and to the risk of haemorrhage often connected with antithrombotic therapy. The results showed that the incidence of deep vein thrombosis was very similar and extremely low in the two groups, only 1 patient in each group having a positive diagnosis on phlebography. The effectiveness of a single daily dose of 15,000 aXaU in orthopaedic surgery was also confirmed. This dose guaranteed effective prophylaxis against the onset of deep vein thrombosis and did not appear to have any local side-effects (such as burning or pain at the site of injection) which could diminish patient compliance.
No takes yet. Share an insight, caveat, or question.
Laguardia et al. (1992) studied Post-operative deep vein thrombosis in hip replacement surgery (n=40). Low molecular weight heparin ('Fluxum') 2 hours before surgery vs. Low molecular weight heparin ('Fluxum') 2 hours after surgery was evaluated on Incidence of deep vein thrombosis. Administering low molecular weight heparin 2 hours before versus 2 hours after hip replacement surgery resulted in similar rates of deep vein thrombosis.
Synapse has enriched 10 related papers. Consider them for comparative context: